Brief: Osmotica Pharmaceuticals Announces Pricing Of $35 Mln Underwritten Public Offering
07/10/2021 05:33
Oct 7 (Reuters) - Osmotica Pharmaceuticals PLC OSMT.O :
* OSMOTICA PHARMACEUTICALS ANNOUNCES PRICING OF $35 MILLION
UNDERWRITTEN PUBLIC OFFERING
* PRICING OF PREVIOUSLY ANNOUNCED UNDERWRITTEN PUBLIC
OFFERING OF
14 MILLION ORDINARY SHARES OF CO AT $2.50 PER SHARE
Source text for Eikon: ID:nGNX9m4kRc
Further company coverage: OSMT.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on RVL Pharmaceuticals
See all newsBrief: RVL Pharmaceuticals Says High Court Of Ireland Made A Winding Up Order In Respect Of Co On Feb 12
Brief: RVL Pharmaceuticals Says Co Issued Petition In Central Office Of High Court In Ireland To Wind Up Company
Brief: RVL Completes Financial Restructuring
Brief: Rvl Pharmaceuticals PLC Received Delisting Notice From Listing Qualifications Department Of Nasdaq Stock Market Llc
U.S. STOCKS ON THE MOVE-Cerevel Therapeutics, Scholar Rock, Helius